We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

CANCER DIAGNOSTICS MARKET ANALYSIS

Cancer Diagnostics Market, By Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)), Imaging (Ultrasound, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others), Biopsy (Needle Biopsy, Endoscopic Biopsy, Bone Marrow Biopsy, Others), Liquid Biopsy Immunohistochemistry In Situ Hybridization), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancers, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others), By End User (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

  • Published In : Jul 2023
  • Code : CMI4029
  • Pages :176
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic

Cancer Diagnostics MarketSize and Trends

The global cancer diagnostics market is estimated to be valued at US$ 59.1 Billion in 2023 and is expected to exhibit a CAGR of 9.6% during the forecast period (2023-2030).

Figure 1. Global Cancer Diagnostics Market Share (%), By Test Type, 2023

Figure 2. Global Cancer Diagnostics Market Value (US$ Billion), by Region, 2023

Market- Trends

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.